LV10612B - Method for producing of 1-benzyl-3-oxy-methylindazole, it's salts and pharmaceutically acceptable carrier - Google Patents

Method for producing of 1-benzyl-3-oxy-methylindazole, it's salts and pharmaceutically acceptable carrier Download PDF

Info

Publication number
LV10612B
LV10612B LVP-93-647A LV930647A LV10612B LV 10612 B LV10612 B LV 10612B LV 930647 A LV930647 A LV 930647A LV 10612 B LV10612 B LV 10612B
Authority
LV
Latvia
Prior art keywords
hjih
quot
pharmaceutically acceptable
salts
benzyl
Prior art date
Application number
LVP-93-647A
Other languages
English (en)
Latvian (lv)
Other versions
LV10612A (lv
Inventor
Bruno Silvestrini
Leandro Baiocchi
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of LV10612A publication Critical patent/LV10612A/xx
Publication of LV10612B publication Critical patent/LV10612B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
LVP-93-647A 1989-02-07 1993-06-22 Method for producing of 1-benzyl-3-oxy-methylindazole, it's salts and pharmaceutically acceptable carrier LV10612B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8947620A IT1230441B (it) 1989-02-07 1989-02-07 Eteri della serie dell'indazolo

Publications (2)

Publication Number Publication Date
LV10612A LV10612A (lv) 1995-04-20
LV10612B true LV10612B (en) 1995-08-20

Family

ID=11261479

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-647A LV10612B (en) 1989-02-07 1993-06-22 Method for producing of 1-benzyl-3-oxy-methylindazole, it's salts and pharmaceutically acceptable carrier

Country Status (36)

Country Link
US (2) US4999367A (fi)
EP (1) EP0382276B1 (fi)
JP (1) JP2870925B2 (fi)
KR (1) KR0145525B1 (fi)
CN (2) CN1046505C (fi)
AR (1) AR247386A1 (fi)
AT (1) ATE127115T1 (fi)
AU (1) AU624895B2 (fi)
BG (1) BG50273A3 (fi)
CA (1) CA2009503C (fi)
CZ (1) CZ280121B6 (fi)
DD (2) DD295363A5 (fi)
DE (2) DE382276T1 (fi)
DK (1) DK0382276T3 (fi)
EG (1) EG19170A (fi)
ES (1) ES2020171T3 (fi)
FI (1) FI102678B (fi)
GE (1) GEP19971030B (fi)
GR (2) GR910300073T1 (fi)
HU (1) HU204793B (fi)
IL (1) IL93132A (fi)
IN (1) IN170957B (fi)
IT (1) IT1230441B (fi)
LT (1) LT3604B (fi)
LV (1) LV10612B (fi)
NZ (1) NZ232258A (fi)
PE (1) PE25091A1 (fi)
PH (1) PH26552A (fi)
PL (2) PL163720B1 (fi)
PT (1) PT93067B (fi)
RO (1) RO106252B1 (fi)
RU (3) RU2066318C1 (fi)
SK (1) SK278441B6 (fi)
UA (1) UA26852C2 (fi)
YU (1) YU47943B (fi)
ZA (1) ZA90644B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
IT1293795B1 (it) 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
US5943270A (en) * 1997-11-26 1999-08-24 Intel Corporation Two-transistor DRAM cell for logic process technology
US7514463B2 (en) 2004-08-20 2009-04-07 University Of Kansas Lonidamine analogues and their use in male contraception and cancer treatment
ITMI20062254A1 (it) 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
EP2254870B1 (en) * 2008-03-07 2016-02-24 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1
US8461194B2 (en) 2008-03-07 2013-06-11 Aziende Chimiche Riunite Angelini Francesco A. C. R. A. F. S. P. A. 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and P40
US8314099B2 (en) 2008-03-07 2012-11-20 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1 and CX3CR1
EP2462119B1 (en) * 2009-08-03 2014-06-11 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Process for the preparation of 1-benzyl-3-hydroxymethyl-1H-indazole and its derivatives and required Magnesium intermediates
UA108742C2 (uk) 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
CA3095012C (en) 2012-05-01 2023-02-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
WO2013171316A1 (en) 2012-05-18 2013-11-21 Sanofi Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation
SI2882715T1 (sl) 2012-05-18 2017-03-31 Sanofi Derivati pirazola in njihova uporaba kot antagonisti LPAR5
CN108047136B (zh) * 2017-12-20 2021-07-09 长春普华制药股份有限公司 一种苄达酸的精制方法
CA3144861A1 (en) * 2019-06-25 2020-12-30 Translatum Medicus, Inc. Processes of making 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives
CN113929627A (zh) * 2021-10-19 2022-01-14 吕梁学院 一种宾达利的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL28032A (en) * 1966-08-29 1971-08-25 Acraf Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof
US3470298A (en) * 1969-01-29 1969-09-30 Acraf Topical anti-inflammatory composition containing (indazole-3-yl)-oxyalkanoic acids
IT1131779B (it) 1980-07-29 1986-06-25 Acraf Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione
IT1189052B (it) 1981-11-27 1988-01-28 Acraf Trattamento della cataratta
IT1194564B (it) 1983-04-18 1988-09-22 Acraf Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa
IT1197805B (it) 1986-08-01 1988-12-06 Acraf Metodo per il tratamento di lenti a contatto

Also Published As

Publication number Publication date
PT93067A (pt) 1990-08-31
HU204793B (en) 1992-02-28
GR910300073T1 (en) 1991-11-15
GR3018165T3 (en) 1996-02-29
ZA90644B (en) 1991-01-30
HU900689D0 (en) 1990-04-28
IN170957B (fi) 1992-06-20
EG19170A (en) 1994-11-30
EP0382276A2 (en) 1990-08-16
BG50273A3 (en) 1992-06-15
PL163720B1 (pl) 1994-04-29
JPH02240065A (ja) 1990-09-25
ATE127115T1 (de) 1995-09-15
NZ232258A (en) 1991-06-25
YU20690A (sh) 1992-07-20
CA2009503A1 (en) 1990-08-07
UA26852C2 (uk) 1999-12-29
YU47943B (sh) 1996-07-24
PL163730B1 (pl) 1994-04-29
CN1046505C (zh) 1999-11-17
IT1230441B (it) 1991-10-23
CA2009503C (en) 2000-04-11
SK56390A3 (en) 1997-05-07
CN1088201A (zh) 1994-06-22
FI900577A0 (fi) 1990-02-06
PE25091A1 (es) 1991-08-17
AR247386A1 (es) 1994-12-29
JP2870925B2 (ja) 1999-03-17
ES2020171A4 (es) 1991-08-01
HUT53088A (en) 1990-09-28
KR0145525B1 (ko) 1998-08-17
US4999367A (en) 1991-03-12
EP0382276A3 (en) 1990-12-12
IT8947620A0 (it) 1989-02-07
DE382276T1 (de) 1991-11-28
DK0382276T3 (da) 1996-01-15
SK278441B6 (en) 1997-05-07
IL93132A0 (en) 1990-11-05
AU4906690A (en) 1990-08-16
DE69021902D1 (de) 1995-10-05
DD291995A5 (de) 1991-07-18
RU2044729C1 (ru) 1995-09-27
EP0382276B1 (en) 1995-08-30
RO106252B1 (ro) 1993-03-31
LV10612A (lv) 1995-04-20
LT3604B (en) 1995-12-27
CZ280121B6 (cs) 1995-11-15
CN1034016C (zh) 1997-02-12
RU2055071C1 (ru) 1996-02-27
PT93067B (pt) 1995-12-29
ES2020171T3 (es) 1995-12-01
LTIP872A (en) 1995-03-27
DD295363A5 (de) 1991-10-31
FI102678B1 (fi) 1999-01-29
GEP19971030B (en) 1997-06-13
KR900012913A (ko) 1990-09-03
PH26552A (en) 1992-08-19
FI102678B (fi) 1999-01-29
AU624895B2 (en) 1992-06-25
CZ56390A3 (en) 1995-06-14
DE69021902T2 (de) 1996-05-23
US5112986A (en) 1992-05-12
RU2066318C1 (ru) 1996-09-10
IL93132A (en) 1994-05-30
CN1044810A (zh) 1990-08-22

Similar Documents

Publication Publication Date Title
LV10612B (en) Method for producing of 1-benzyl-3-oxy-methylindazole, it's salts and pharmaceutically acceptable carrier
US3369025A (en) 3-pyridylmethyl phenoxy (phenylthio and anilino) alkanoates
RU2001904C1 (ru) Способ получени хиноновых производных
USRE32581E (en) Certain substituted phenyl esters of nicotinic acid, compositions and methods of using same for treatment of hyperlipidemia
IL62485A (en) Glycerol-3-phosphoric acid halogenoalkyl esters and processes for their preparation and further conversion to phospholipids
US4758580A (en) Inhibiting growth of tumors with certain substituted phenoxy dimethyl alkanoic acids, esters or salts
HUT58312A (en) Process for producing new 4-quinolyl-dihydropyridine derivatives and pharmaceutical compositions containing them
JPS56142236A (en) Ml-236a and mb-530a derivative
EP1617843B1 (en) Colchicine derivatives
US4902820A (en) Preparation of α-acyloxycarbonyl compounds
Murthy et al. Synthesis and Hypolipidemic Activity of 3-Imino-l-oxoisoindolines in Rodents
ES8305727A1 (es) Procedimiento de preparacion de derivados del 3,4-difenil-5-metil pirazol.
SU1192619A3 (ru) Способ получени солей 4-(9-акридиниламино)-метансульфон-м-анизидина
Kokosa et al. Deoxidative substitution of pyridine N-oxides. XII. Revised structures of some tetrahydropyridines isolated from the reaction of pyridine N-oxides with mercaptans and acid anhydrides
IL22617A (en) Amides of Nano-Carboxoxyalkyl Paneoxy and N-Carboxoxyalkyl-Anilanoicanoic Acids
JPS56161388A (en) Novel vincamine derivative
CA1076577A (en) Process for preparing hydrazinopyridazine derivatives
US4647412A (en) Anti-tumor derivatives of butanediol and process of preparation
Costantino et al. The stereochemistry of crasserides
DE2217404C3 (de) Neue herzwirksame Cardenolid-Rhamnoside
JPS5782390A (en) Carbostyril derivative
JPS5655383A (en) Amizine derivative and its preparation
JPS57142926A (en) Preparation of difluoroethene derivative
KR840002268B1 (ko) 치환된 페놀에스테르의 제조방법
JPS5455562A (en) Lactam compound